(TMHC) Taylor Morn Home - Ratings and Ratios
Homes, Developments, Communities, Properties
TMHC EPS (Earnings per Share)
TMHC Revenue
Description: TMHC Taylor Morn Home July 28, 2025
Taylor Morrison Home Corporation is a leading US homebuilder and land developer, operating across multiple states with a diverse portfolio of brands, including Taylor Morrison, Darling Homes Collection, and Esplanade. The company designs, builds, and sells a range of homes, from single-family detached homes to multi-family attached homes, and develops master-planned communities and multi-use properties.
The companys business model is diversified across various segments, including homebuilding, land development, and financial services, such as title insurance and closing settlement services. Taylor Morrison Home Corporation also has a presence in the build-to-rent market through its Yardly brand. With operations in 13 states, the company has a significant geographic footprint, allowing it to capitalize on regional market trends.
From a financial perspective, Taylor Morrison Home Corporation has demonstrated a strong return on equity (RoE) of 15.75%, indicating efficient use of shareholder capital. The companys price-to-earnings (P/E) ratio is 7.24, which is relatively low compared to its peers, suggesting potential undervaluation. Additionally, the companys market capitalization is approximately $6.24 billion, indicating a significant market presence.
To further analyze the companys performance, key performance indicators (KPIs) such as revenue growth, gross margin, and homebuilding margins can be examined. For instance, the companys revenue growth rate, average selling price (ASP) of homes, and gross margin percentage can provide insights into its operational efficiency and pricing power. Furthermore, metrics such as land holdings, lot count, and community count can help assess the companys growth prospects and ability to execute its business plan.
TMHC Stock Overview
| Market Cap in USD | 5,969m |
| Sub-Industry | Homebuilding |
| IPO / Inception | 2013-04-10 |
TMHC Stock Ratings
| Growth Rating | 53.1% |
| Fundamental | 66.5% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -26.8% |
| Analyst Rating | 4.30 of 5 |
TMHC Dividends
Currently no dividends paidTMHC Growth Ratios
| Growth Correlation 3m | -23.2% |
| Growth Correlation 12m | -12.3% |
| Growth Correlation 5y | 88.6% |
| CAGR 5y | 31.45% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.13 |
| CAGR/Mean DD 3y (Pain Ratio) | 3.56 |
| Sharpe Ratio 12m | -0.77 |
| Alpha | -32.62 |
| Beta | 1.614 |
| Volatility | 35.87% |
| Current Volume | 1172.9k |
| Average Volume 20d | 1070.2k |
| Stop Loss | 58 (-3.9%) |
| Signal | -0.30 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (853.6m TTM) > 0 and > 6% of Revenue (6% = 502.7m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 5.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 77.90% (prev 81.08%; Δ -3.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 619.3m <= Net Income 853.6m (YES >=105%, WARN >=100%) |
| Net Debt (1.89b) to EBITDA (1.28b) ratio: 1.48 <= 3.0 (WARN <= 3.5) |
| Current Ratio 7.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (100.0m) change vs 12m ago -5.69% (target <= -2.0% for YES) |
| Gross Margin 23.96% (prev 24.45%; Δ -0.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 88.53% (prev 84.21%; Δ 4.32pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 30.59 (EBITDA TTM 1.28b / Interest Expense TTM 40.9m) >= 6 (WARN >= 3) |
Altman Z'' 8.56
| (A) 0.68 = (Total Current Assets 7.60b - Total Current Liabilities 1.07b) / Total Assets 9.63b |
| (B) 0.52 = Retained Earnings (Balance) 5.00b / Total Assets 9.63b |
| (C) 0.13 = EBIT TTM 1.25b / Avg Total Assets 9.46b |
| (D) 1.46 = Book Value of Equity 5.00b / Total Liabilities 3.43b |
| Total Rating: 8.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.46
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 7.38% = 3.69 |
| 3. FCF Margin 6.92% = 1.73 |
| 4. Debt/Equity 0.37 = 2.43 |
| 5. Debt/Ebitda 1.48 = 1.00 |
| 6. ROIC - WACC (= 2.88)% = 3.60 |
| 7. RoE 14.20% = 1.18 |
| 8. Rev. Trend 13.15% = 0.99 |
| 9. EPS Trend 16.68% = 0.83 |
What is the price of TMHC shares?
Over the past week, the price has changed by -2.86%, over one month by -8.91%, over three months by -0.40% and over the past year by -13.65%.
Is Taylor Morn Home a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TMHC is around 65.80 USD . This means that TMHC is currently overvalued and has a potential downside of 9.03%.
Is TMHC a buy, sell or hold?
- Strong Buy: 4
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TMHC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.6 | 23.7% |
| Analysts Target Price | 74.6 | 23.7% |
| ValueRay Target Price | 73.6 | 21.9% |
TMHC Fundamental Data Overview October 25, 2025
P/E Trailing = 7.359
P/E Forward = 10.6045
P/S = 0.7124
P/B = 1.0984
P/EG = 1.511
Beta = 1.614
Revenue TTM = 8.38b USD
EBIT TTM = 1.25b USD
EBITDA TTM = 1.28b USD
Long Term Debt = 2.12b USD (from longTermDebt, last fiscal year)
Short Term Debt = 73.0m USD (from shortTermDebt, last quarter)
Debt = 2.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.89b USD (from netDebt column, last quarter)
Enterprise Value = 7.86b USD (5.97b + Debt 2.26b - CCE 370.6m)
Interest Coverage Ratio = 30.59 (Ebit TTM 1.25b / Interest Expense TTM 40.9m)
FCF Yield = 7.38% (FCF TTM 580.0m / Enterprise Value 7.86b)
FCF Margin = 6.92% (FCF TTM 580.0m / Revenue TTM 8.38b)
Net Margin = 10.19% (Net Income TTM 853.6m / Revenue TTM 8.38b)
Gross Margin = 23.96% ((Revenue TTM 8.38b - Cost of Revenue TTM 6.37b) / Revenue TTM)
Gross Margin QoQ = 22.74% (prev 23.56%)
Tobins Q-Ratio = 0.82 (Enterprise Value 7.86b / Total Assets 9.63b)
Interest Expense / Debt = 0.56% (Interest Expense 12.8m / Debt 2.26b)
Taxrate = 24.94% (67.9m / 272.4m)
NOPAT = 939.9m (EBIT 1.25b * (1 - 24.94%))
Current Ratio = 7.09 (Total Current Assets 7.60b / Total Current Liabilities 1.07b)
Debt / Equity = 0.37 (Debt 2.26b / totalStockholderEquity, last quarter 6.18b)
Debt / EBITDA = 1.48 (Net Debt 1.89b / EBITDA 1.28b)
Debt / FCF = 3.26 (Net Debt 1.89b / FCF TTM 580.0m)
Total Stockholder Equity = 6.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.87% (Net Income 853.6m / Total Assets 9.63b)
RoE = 14.20% (Net Income TTM 853.6m / Total Stockholder Equity 6.01b)
RoCE = 15.40% (EBIT 1.25b / Capital Employed (Equity 6.01b + L.T.Debt 2.12b))
RoIC = 11.67% (NOPAT 939.9m / Invested Capital 8.05b)
WACC = 8.79% (E(5.97b)/V(8.23b) * Re(11.96%) + D(2.26b)/V(8.23b) * Rd(0.56%) * (1-Tc(0.25)))
Discount Rate = 11.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.18%
[DCF Debug] Terminal Value 65.15% ; FCFE base≈356.0m ; Y1≈353.4m ; Y5≈369.4m
Fair Price DCF = 37.91 (DCF Value 3.70b / Shares Outstanding 97.7m; 5y FCF grow -1.47% → 3.0% )
EPS Correlation: 16.68 | EPS CAGR: -8.33% | SUE: 0.96 | # QB: 1
Revenue Correlation: 13.15 | Revenue CAGR: -6.10% | SUE: 0.65 | # QB: 0
Additional Sources for TMHC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle